Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study.

Gil, Miguel

Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study. [electronic resource] - British journal of clinical pharmacology Dec 2011 - 965-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1365-2125

10.1111/j.1365-2125.2011.04031.x doi


Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--administration & dosage
Cohort Studies
Cyproterone Acetate--administration & dosage
Databases, Factual--statistics & numerical data
Dose-Response Relationship, Drug
Female
Follow-Up Studies
Humans
Incidence
Male
Medical Records Systems, Computerized--statistics & numerical data
Meningioma--chemically induced
Middle Aged
Poisson Distribution
Primary Health Care
Regression Analysis
Retrospective Studies
Risk
Sex Factors
Spain
Time Factors
Young Adult